Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tulsi for Neurocognition and Stress
NCT03184909Completed
- Sponsor
- Composite Interceptive Med-Science Laboratories
- Start
- Dec 2017
- Primary completion
- Mar 2018
- Countries
- 1
01
Overview
Randomised, double-blind trial (2 arms), sponsored by Composite Interceptive Med-Science Laboratories. Primary endpoint: Facilitative cognitive function at 6 weeks. Started Dec 2017; status: completed.
Beyond the preview
Go deeper on NCT03184909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03184909.